abstract |
The present invention provides a pharmaceutical agent having an inhibitory activity against ENPP2, which is a target different from an existing drug, as a pharmaceutical product having a urinary dysfunction patient having insufficient therapeutic effect on an existing drug.nThe present invention provides a formula (I) having ENPP2 inhibitory activity:n□n(wherein, the definition of each group means the same meaning as the content described in the specification), the compound represented by the salt, or a solvate thereof, or a prodrug thereof, and a urinary dysfunction containing the same as an active ingredient A preventive, therapeutic and/or symptomatic agent. |